Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|April 26, 2017
Targeting secondary protein complexes in drug discovery: studying the druggability and chemical biology of the HSP70/BAG1 complexLindsay E Evans, Keith Jones, Matthew D CheesemanOrganic Letters|June 28, 2012
N-N bond-forming cyclization for the one-pot synthesis of N-aryl[3,4-d]pyrazolopyrimidinesLindsay E Evans, Matthew D Cheeseman, Keith JonesPlos One|October 13, 2015
Investigating Apoptozole as a Chemical Probe for HSP70 InhibitionLindsay E Evans, Matthew D Cheeseman, Norhakim Yahya, et al.Journal of Medicinal Chemistry|April 23, 2019
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial ProdrugLindsay E Evans, Aishwarya Krishna, Yajing Ma, et al.Bioorganic & Medicinal Chemistry|July 17, 2019
Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureusCarine S Q Lim, Kam Pou Ha, Rebecca S Clarke, et al.Elife|April 6, 2021
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membraneAkshay Sabnis, Katheryn Lh Hagart, Anna Klöckner, et al.Journal of Medicinal Chemistry|January 12, 2026
Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC JB170 to CCT400028, an In Vitro Degrader Chemical ProbeJack A O'Hanlon, Katrin Gutsche, Juliane Elisabeth Müller, et al.ACS Medicinal Chemistry Letters|January 8, 2019
Privileged Structures and Polypharmacology within and between Protein FamiliesJoshua Meyers, Nicola E A Chessum, Salyha Ali, et al.Journal of Medicinal Chemistry|April 5, 2023
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other MalignanciesA Elisa Pasqua, Swee Y Sharp, Nicola E A Chessum, et al.Journal of Medicinal Chemistry|December 23, 2016
Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic ScreenMatthew D Cheeseman, Nicola E A Chessum, Carl S Rye, et al.Pageof 1